lorazepam has been researched along with methylprednisolone in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Artal, A; Chacón, JI; Feliu, J; García de Paredes, ML; García Girón, C; Garrido, P; González Barón, M; Herranz, C; Ordóñez Gallego, A; Zamora, P | 1 |
| Baldini, E; Bruzzi, P; Campora, E; Chiara, S; Rosso, R; Rubagotti, A; Sertoli, MR | 1 |
| Guillén Lloveria, G; Mayordomo Cámara, JJ; Sáenz Cusi, A; Sáez Martínez, MJ; Tres Sánchez, A | 1 |
| Fiumara, AM; Kearsley, JH; Williams, AM | 1 |
| Bertetto, O; Cardinali, C; Clerico, M; Giaccone, G; Morandini, MP | 1 |
| Bonneterre, J; Harousseau, JL; Hedouin, M; Ouvry, J; Zittoun, R | 1 |
| Bellini, C; Bussi, M; Martino, G; Piccioni, LO; Teggi, R | 1 |
| Kenedi, C; West, S | 1 |
| Ferrell, CL | 1 |
| Martin-Gill, C; Ramgopal, S | 1 |
3 review(s) available for lorazepam and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Stiff-person syndrome with acute recurrent peripheral vertigo: possible evidence of gamma aminobutyric acid as a neurotransmitter in the vestibular periphery.
Topics: Autoantibodies; Electromyography; GABA Agents; GABA Modulators; gamma-Aminobutyric Acid; Humans; Lorazepam; Male; Methylprednisolone; Middle Aged; Neuroprotective Agents; Stiff-Person Syndrome; Vertigo | 2008 |
Strategies to prevent the neuropsychiatric side-effects of corticosteroids: a case report and review of the literature.
Topics: Adult; Amines; Benzodiazepines; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Lithium Compounds; Lorazepam; Methylprednisolone; Olanzapine; Polyarteritis Nodosa; Prednisone; Psychoses, Substance-Induced | 2014 |
6 trial(s) available for lorazepam and methylprednisolone
| Article | Year |
|---|---|
Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
Topics: Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Vomiting | 1991 |
Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Humans; Injections, Intramuscular; Injections, Intravenous; Lorazepam; Methotrexate; Methylprednisolone; Middle Aged; Vomiting | 1990 |
[Antiemetic treatments associated with antineoplastic chemotherapy].
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lorazepam; Methylprednisolone; Metoclopramide; Vincristine; Vomiting | 1990 |
Antiemetic superiority of lorazepam over oxazepam and methylprednisolone as premedicants for patients receiving cisplatin-containing chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Female; Humans; Lorazepam; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasms; Oxazepam; Vomiting | 1989 |
Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design.
Topics: Adult; Aged; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Methylprednisolone; Metoclopramide; Middle Aged; Neoplasms; Vomiting | 1993 |
[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination].
Topics: Adult; Antiemetics; Breast Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Lorazepam; Male; Methylprednisolone; Middle Aged; Nausea; Ondansetron; Patient Satisfaction; Quality of Life; Vomiting | 2000 |
8 other study(ies) available for lorazepam and methylprednisolone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Anaphylactic Reaction to Methylprednisolone.
Topics: Anaphylaxis; Calcium Channel Blockers; Emergency Nursing; Female; GABA Modulators; Glucocorticoids; Humans; Lorazepam; Magnesium Sulfate; Methylprednisolone; Middle Aged | 2015 |
Deviation From National Dosing Recommendations for Children Having Out-of-Hospital Emergencies.
Topics: Child; Diazepam; Emergencies; Emergency Medical Services; Epinephrine; Hospitals; Humans; Ketorolac; Lorazepam; Methylprednisolone; Morphine | 2023 |